Pharmicell Co Ltd banner

Pharmicell Co Ltd
KRX:005690

Watchlist Manager
Pharmicell Co Ltd Logo
Pharmicell Co Ltd
KRX:005690
Watchlist
Price: 10 770 KRW 1.41% Market Closed
Market Cap: ₩646.2B

Wall St Price Targets

Price Targets Summary
Pharmicell Co Ltd

Wall Street analysts forecast Pharmicell Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Pharmicell Co Ltd is 26 520 KRW with a low forecast of 26 260 KRW and a high forecast of 27 300 KRW.

Lowest Forecast
Price Target
26 260 KRW
144% Upside
Average Forecast
Price Target
26 520 KRW
146% Upside
Highest Forecast
Price Target
27 300 KRW
153% Upside
Pharmicell Co Ltd Competitors:
Price Targets
TCPC
BlackRock TCP Capital Corp
10% Upside
CDNA
CareDx Inc
5% Upside

Revenue
Forecast

20% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
20% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 44%.

Gross Profit
Forecast

32% / Year
Past Growth
97% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
32% / Year
Past Growth
97% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 1 year is 97%.

Operating Income
Forecast

N/A
Past Growth
60% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
60% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Operating Income over the next 3 years is 60%.

Pre-Tax Income
Forecast

N/A
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
N/A
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 1 year is 71%.

Net Income
Forecast

N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate for Net Income over the next 3 years is 41%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Pharmicell Co Ltd's stock price target?
Price Target
26 520 KRW

According to Wall Street analysts, the average 1-year price target for Pharmicell Co Ltd is 26 520 KRW with a low forecast of 26 260 KRW and a high forecast of 27 300 KRW.

What is the Revenue forecast for Pharmicell Co Ltd?
Projected CAGR
44%

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 44%.

What is the Gross Profit forecast for Pharmicell Co Ltd?
Projected CAGR
97%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 1 year is 97%.

What is the Operating Income forecast for Pharmicell Co Ltd?
Projected CAGR
60%

The compound annual growth rate for Operating Income over the next 3 years is 60%.

What is the Pre-Tax Income forecast for Pharmicell Co Ltd?
Projected CAGR
71%

The compound annual growth rate for Pre-Tax Income over the next 1 year is 71%.

What is the Net Income forecast for Pharmicell Co Ltd?
Projected CAGR
41%

The compound annual growth rate for Net Income over the next 3 years is 41%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett